Tianjin Medical Journal ›› 2020, Vol. 48 ›› Issue (4): 343-347.doi: 10.11958/20192717
• Review • Previous Articles Next Articles
LIU Hong-fei, WEI Cui-ying△ #br#
Received:
Revised:
Published:
Online:
Contact:
Supported by:
LIU Hong-fei, WEI Cui-ying. Research progress of STAT3 signaling pathway in insulin resistance #br#[J]. Tianjin Medical Journal, 2020, 48(4): 343-347.
Abstract: Insulin resistance (IR) is an important mechanism of type 2 diabetes. It affects the transmission of various signaling pathways, thereby disrupting glucose metabolism. Signaling and the transcriptional activation factor 3 (STAT3) pathway are important pathways that regulate gene transcription. There is evidence that STAT3 signaling pathway is a key factor of IR, which can regulate the mitogen-activated protein kinase (MAPK) pathway, insulin receptor substrate-1 (IRS-1) /phosphatidyl inositol 3 kinase (P13K) / protein kinase B (PKB) pathway and other insulin-related pathways. The STAT3 signaling pathway is activated by the upstream cytokine interleukin-22 (IL-22) and is involved in the regulation of glucose metabolism. It is a current research hotspot. This article reviews the relationship between the STAT3 pathway and IR to further clarify the pathogenesis of glucose metabolism.
Key words: diabetes mellitus, type 2, STAT3 signaling pathway, insulin resistance
CLC Number:
R349.14 ','1');return false;" target="_blank"> R349.14
/ Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.tjyybjb.ac.cn/EN/10.11958/20192717
https://www.tjyybjb.ac.cn/EN/Y2020/V48/I4/343